Development and Clinical Master Services Agreement Sample Contracts

DEVELOPMENT AND CLINICAL MASTER SERVICES AGREEMENT

Development and Clinical Master Services Agreement • March 9th, 2021 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New Jersey

• Contract Type
  Development and Clinical Master Services Agreement
• Filed
  March 9th, 2021
• Company
  Evelo Biosciences, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New Jersey

This Development and Clinical Master Services Agreement (this “Agreement”) is effective as of December 17, 2020 (the “Effective Date”) by and between Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, a Delaware corporation (“Cambrex”), and Evelo Biosciences, Inc., a Delaware corporation (“Client”).

Amendment No. 1 to Development and Clinical Master Services Agreement

Development and Clinical Master Services Agreement • March 24th, 2022 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New Jersey

• Contract Type
  Development and Clinical Master Services Agreement
• Filed
  March 24th, 2022
• Company
  Evelo Biosciences, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New Jersey

This Amendment No. 1 (this “Amendment”), dated as of February 8, 2022 (“Amendment Effective Date”), between Evelo Biosciences, Inc. (the “Client”) and Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany (the “Cambrex”) amends that certain Development and Clinical Master Services Agreement, dated December 17, 2020, between the Client and Cambrex (the “Agreement”). The Client and Cambrex are each referred to herein as a “Party” and, collectively, as the “Parties.” Capitalized terms used and not otherwise defined in this Amendment shall have the meanings set forth in the Agreement.